Merck

June 2, 2017

Patients Being Recruited for Phase 2 Trial of Keytruda and Chemoradiation in Cervical Cancer

News

Cervical cancer patients are being recruited for a Phase 2 clinical trial of a combination of Keytruda (pembrolizumab) and chemoradiation therapy. The randomized trial (NCT02635360) is expected to include about 88 ... Read more

May 26, 2017

Keytruda Shows Promise in People with Advanced Disease, Early Phase 2 Trial Results Show

News

Merck’s Keytruda (pembrolizumab) shows promise as a treatment for advanced, previously treated cervical squamous cell cancer, according to a preliminary analysis of a Phase 2 trial. The data, which will ... Read more